A combination of immunotherapies may hold promise for kidney cancer By Sharon Kell|2016-10-06T13:28:56+00:006 Oct 2016|Drug treatments| A combination of the PD-1 inhibitor pembrolizumab (Keytruda) with another [...] Read More Comments Off on A combination of immunotherapies may hold promise for kidney cancer